POLYGYNAX, capsule vaginal 6 capsules
Active ingredients: Nystatin, Neomycin sulfate, Polymyxin b1 sulfate
Commercialized according to BDPMDispensing in France: Prescription only
Capsule6 capsulesvaginale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- POLYGYNAX, capsule vaginale
- Pharmaceutical form
- capsule
- Route of administration
- vaginale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 6 capsule(s)
- Marketing authorisation holder
- INNOTECH INTERNATIONAL
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 19 Apr 2012
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66085108CIP74948351CIP133400949483518Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NYSTATINEcapsule | 100 000 Ul · une capsule | SA |
| SULFATE DE POLYMYXINE Bcapsule | 35 000 UI · une capsule | SA |
| SULFATE DE NÉOMYCINEcapsule | 35 000 Ul · une capsule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.